Wang C, Li Y, Chu C-M, Zhang X-M, Ma J, Huang H, Wang Y-N, Hong T-Y, Zhang J, Pan X-W et al..
2019.
Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.. EBioMedicine. 39:255-264.
Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T, Ma X, Ma Y, Iadecola C, M Beal F et al..
2010.
Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice.. J Exp Med. 207(1):117-28.
Liao L, Song M, Li X, Tang L, Zhang T, Zhang L, Pan Y, Chouchane L, Ma X.
2017.
E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.. Cancer Res. 77(8):2090-2101.
Hu W, Zi Z, Jin Y, Li G, Shao K, Cai Q, Ma X, Wei F.
2019.
CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions.. Cancer Immunol Immunother. 68(3):365-377.
Jiao X, Katiyar S, Willmarth NE, Liu M, Ma X, Flomenberg N, Lisanti MP, Pestell RG.
2010.
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.. J Biol Chem. 285(11):8218-26.
Lv D, Zhang Y, Kim H-J, Zhang L, Ma X.
2013.
CCL5 as a potential immunotherapeutic target in triple-negative breast cancer.. Cell Mol Immunol. 10(4):303-10.
Wang H, Wang C, Peng G, Yu D, Cui X-G, Sun Y-H, Ma X.
2020.
Capping Protein Regulator and Myosin 1 Linker 3 Is Required for Tumor Metastasis.. Mol Cancer Res. 18(2):240-252.
Tripathi P, Madan R, Chougnet C, Divanovic S, Ma X, Wahl LM, Gajewski T, Karp CL, Hildeman DA.
2006.
An adenoviral vector for probing promoter activity in primary immune cells.. J Immunol Methods. 311(1-2):19-30.